Last reviewed · How we verify

NCT03921281

Evaluating the Therapeutic Effect of Scalp Acupuncture Treatment for Motor Dysfunction in Children With Cerebral Palsy

Completed NA Last updated 28 February 2023
What this trial tests

NA trial testing scalp acupuncture treatment in Cerebral Palsy in 100 participants. Completed in 31 December 2022.

Timeline
1 December 2018
Primary endpoint
1 December 2022
31 December 2022

Quick facts

Lead sponsorChildren's Hospital of Fudan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date1 December 2018
Primary completion1 December 2022
Estimated completion31 December 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 12 Months to 72 Months, any sex, with Cerebral Palsy or Motor Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators design a Multi-center randomized, control study to evaluate the therapeutic effect of the scalp acupuncture treatment for motor dysfunction in children with cerebral palsy by using the following outcomes: motor function, activity of daily living, quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Acupuncture treatment on the motor area of the scalp for motor dysfunction in children with cerebral palsy: study protocol for a multicenter randomized controlled trial.
    Wang J, Shi W, Khiati D, Shi B, et al · · 2020 · cited 9× · PMID 31907027 · DOI 10.1186/s13063-019-3986-z

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03921281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing